London-based LabGenius, which makes use of ML to seek out and design antibody therapies to deal with most cancers, raised a £35M Collection B led by Merck's VC arm, M Ventures (Mimi Billing/Sifted)
Mimi Billing / Sifted: London-based LabGenius, which makes use of ML to seek out and design antibody therapies to deal ...
